Hervé Curé

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone et al. · The Lancet Oncology · 2012 · 742 citations

Medicine, Oncology, Pharmacology +16

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

Pierre Soubeyran, Carine Bellera, Jean Goyard et al. · PLoS ONE · 2014 · 579 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

Henri Roché, Louise Yelle, Francesco Cognetti et al. · Journal of Clinical Oncology · 2007 · 225 citations

Medicine, Oncology, Pharmacology +16

Low grade supratentorial astrocytomas. Management and prognostic factors

P Janny, Hervé Curé, Michel Mohr et al. · Cancer · 1994 · 187 citations · Full text

Medicine, Oncology, Surgery +16

¹⁸F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

Géraldine Gebhart, Eileen Holmes, Javier Robles et al. · Journal of Nuclear Medicine · 2013 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17